{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:41:36Z","timestamp":1769838096042,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ajo.2007.08.027","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T17:15:53Z","timestamp":1196788553000},"page":"124-129.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Topical Interferon Alfa in the Treatment of Conjunctival Melanoma and Primary Acquired Melanosis Complex"],"prefix":"10.1016","volume":"145","author":[{"given":"Paul T.","family":"Finger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragui W.","family":"Sedeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly J.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2007.08.027_bib1","first-page":"3399","article-title":"Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites","volume":"43","author":"Tuomaala","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2007.08.027_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0002-9394(02)02288-2","article-title":"Conjunctival melanoma: is it increasing in the United States?","volume":"135","author":"Yu","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00417-004-1080-y","article-title":"Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years\u2019 experience","volume":"243","author":"Kurli","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0161-6420(88)33058-7","article-title":"Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma","volume":"95","author":"Jakobiec","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.08.027_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0039-6257(97)00122-7","article-title":"Conjunctival melanoma","volume":"42","author":"Seregard","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bjo.77.11.751","article-title":"Topical chemotherapy for conjunctival melanoma","volume":"77","author":"Finger","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bjo.82.5.476","article-title":"Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia","volume":"82","author":"Finger","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/bjo.2006.092734","article-title":"Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia","volume":"90","author":"Finger","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0039-6257(00)00210-1","article-title":"Chemotherapy for eye cancer","volume":"45","author":"Wilson","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00003226-200401000-00016","article-title":"A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles","volume":"23","author":"Di Pascuale","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2007.08.027_bib11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.ophtha.2004.01.034","article-title":"Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa-2b","volume":"111","author":"Boehm","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.08.027_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0161-6420(99)90009-X","article-title":"Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia","volume":"106","author":"Vann","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.08.027_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003226-200201000-00003","article-title":"Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b","volume":"21","author":"Schechter","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2007.08.027_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9394(14)71412-6","article-title":"Conjunctival Kaposi\u2019s sarcoma treated with interferon alpha-2a","volume":"116","author":"Hummer","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0161-6420(02)01838-9","article-title":"Do you speak ocular tumor?","volume":"110","author":"Finger","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.08.027_bib16","series-title":"AJCC cancer staging manual","first-page":"347","article-title":"Part XI: ophthalmic sites","author":"Haik","year":"2002"},{"key":"10.1016\/j.ajo.2007.08.027_bib17","first-page":"1231","article-title":"[TNM classification of ophthalmic malignant tumors]","volume":"25","author":"Kaneko","year":"1998","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.ajo.2007.08.027_bib18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bjo.2004.064204","article-title":"\u201cFinger-tip\u201d cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia","volume":"89","author":"Finger","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib19","first-page":"664","article-title":"Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma: a pilot study","volume":"67","author":"Bartlett","year":"1996","journal-title":"J Am Optom Assoc"},{"key":"10.1016\/j.ajo.2007.08.027_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archopht.121.2.168","article-title":"High-frequency ultrasonographic evaluation of conjunctival intraepithelial neoplasia and squamous cell carcinoma","volume":"121","author":"Finger","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib21","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1200\/JCO.2005.05.2498","article-title":"Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses","volume":"24","author":"Moschos","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajo.2007.08.027_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.suronc.2006.05.003","article-title":"The treatment of melanoma with an emphasis on immunotherapeutic strategies","volume":"15","author":"Jack","year":"2006","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ajo.2007.08.027_bib23","first-page":"51","article-title":"[A case of conjunctival malignant melanoma treated with subconjunctival injection of interferon beta\u2014efficacy and side effects]","volume":"110","author":"Fujioka","year":"2006","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ajo.2007.08.027_bib24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ajo.2003.10.048","article-title":"Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia","volume":"137","author":"Dudney","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.08.027_bib25","first-page":"885","article-title":"Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations","volume":"118","author":"Demirci","year":"2000","journal-title":"Arch Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407007726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407007726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:55:12Z","timestamp":1757595312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939407007726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0002939407007726"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2007.08.027","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Interferon Alfa in the Treatment of Conjunctival Melanoma and Primary Acquired Melanosis Complex","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2007.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}